Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $95.7800 (2.99%) ($91.8200 - $95.8000) on Mon. May. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.31% (three month average) | RSI | 57 | Latest Price | $95.7800(2.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND advances 2.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(53%) XBI(51%) IWC(48%) IWM(48%) | Factors Impacting LGND price | LGND will decline at least -3.155% in a week (0% probabilities). VIXM(-25%) VXX(-16%) UUP(-16%) UNG(-2%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.155% (StdDev 6.31%) | Hourly BBV | 0 () | Intraday Trend | 2.6% | | | |
|
5 Day Moving Average | $96.33(-0.57%) | 10 Day Moving Average | $96.18(-0.42%) | 20 Day Moving Average | $92.15(3.94%) | To recent high | -11.2% | To recent low | 51.1% | Market Cap | $1.539b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |